TriSalus Life Sciences, Inc. Increase (Decrease) in Accrued Liabilities
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-03-22
- TriSalus Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was $361.05K.
- TriSalus Life Sciences, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $385.32K, a 59.63% decline from fiscal 2021.
- TriSalus Life Sciences, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $954.40K.
| Period end | Increase (Decrease) in Accrued Liabilities 1 month | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 4 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $385.32K 10-K · filed 2023-03-22 | ||||
| 2021-12-31 | $361.05K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-22 | $954.40K 10-K · filed 2023-03-22 | |||
| 2021-09-30 | $593.35K 10-Q/A · filed 2021-12-13 | ||||
| 2020-12-31 | $103.22K 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | $1.00K 10-Q/A · filed 2021-12-13 |